Tag: Erytech
ERYTECH announces the procedures for making the preparatory documents available for the Combined General Meeting of June 24, 2022 – 05/24/2022 at 10:05 p.m.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Lyon (France), and Cambridge, MA…
ERYTECH announces the procedures for making the preparatory documents available for the Combined General Meeting of June 24, 2022 – 05/24/2022 at 10:05 p.m.
ERYTECH announces the terms of provision preparatory documents for the Combined General Meeting of 2 4 June 2022 Lyon (France), and Cambridge, MA (US) the 24 May 2 022 –…
ERYTECH will hold a presentation at the HC Wainwright Global Investment conference – 05/17/2022 at 22:05
ERYTECH hold a presentation to the conference HC Wainwright Global Investment Lyons ( France ), and Cambridge, MA (US) the 1 7 May 2 022 – ERYTECH Pharmaceuticals (Euronext &…
ERYTECH will hold a presentation at the HC Wainwright Global Investment conference – 05/17/2022 at 22:05
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Lyon (France), and Cambridge, MA…
ERYTECH announces the filing of its 2021 Universal Registration Document and its 2021 Form 20-F, as well as its 2022 financial calendar
ERYTECH announces the deposit of its 2021 Universal Registration Document and sound Form 20-F 2021, as well as its 2022 financial calendar Lyon, France), Cambridge, MA (US) the 28 april…
Erytech Pharma: sells its American site for $44.5 million – 04/25/2022 at 09:42
(CercleFinance.com) – Erytech Pharma announces today the sale of its American production site in Princeton to Catalent – a contract development and manufacturing company (CDMO) presented as a ‘leader in…
Erytech Pharma: sale of its US production site and supply agreement – 04/25/2022 at 09:53
(AOF) – Erytech Pharma gains more than 5% to 1.26 euros. The clinical-stage biopharmaceutical company that develops innovative therapies by encapsulating drugs in red blood cells, today announced the sale…
Erytech Pharma: Armistice Capital holds less than 5%
(CercleFinance.com) – Armistice Capital, acting on behalf of the Armistice Capital Master Fund, which it manages, declared that on April 7, 2022 it crossed the threshold of 5% of the…
ERYTECH announces the publication of positive results from the phase 2 trial evaluating eryaspase in hypersensitive ALL in the British Journal of Haematology – 04/06/2022 at 22:05
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Lyon (France), and Cambridge, MA…
ERYTECH will present a new vesiculation approach at the 24th Congress of the European Red Blood Cell Society (ERCS) – 04/04/2022 at 07:30
ERYTECH will present a new approach to vesiculation to 24 th Congress of the society European Red Blood Cells (ERCS) Oral presentation of the study of feasibility of producing extracellular…
ERYTECH will present a new vesiculation approach at the 24th Congress of the European Red Blood Cell Society (ERCS) – 04/04/2022 at 07:30
ERYTECH Pharma (Euronext: ERYP; Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells (RBCs), today announced the presentation of its novel RBC vesiculation…
ERYTECH announces its participation in investor conferences in April – 03/28/2022 at 22:05
ERYTECH announces its participation at investor conferences in April Lyon, France), and Cambridge, MA (US) the 28th March 202 2 – ERYTECH Pharma (Euronext: ERYP ; Nasdaq: ERYP), company clinical-stage…